Lymphocyte recovery and clinical response in multiple myeloma patients receiving interferon CX2f after intensive therapy
1996

Lymphocyte Recovery in Multiple Myeloma Patients Receiving Interferon After Intensive Therapy

Sample size: 69 publication Evidence: moderate

Author Information

Author(s): BC Millar, JBG Bell, RL Powles

Primary Institution: Institute of Cancer Research and the Royal Marsden NHS Trust

Hypothesis

Does maintenance therapy with interferon a2 enhance the recovery of lymphocyte subsets in multiple myeloma patients after intensive therapy?

Conclusion

The study found no enhanced recovery of specific lymphocyte subsets in patients receiving interferon a2 as maintenance therapy after intensive treatment.

Supporting Evidence

  • Patients receiving interferon a2 had significantly lower total white blood cell counts compared to those who had no further treatment.
  • Natural killer (NK) activity was not significantly different between patients on interferon and normal volunteers.
  • Despite the use of interferon, the recovery of CD4+ lymphocytes remained significantly below normal levels.

Takeaway

This study looked at how a medicine called interferon affects the immune cells in patients with a type of blood cancer called multiple myeloma after they received strong treatment. It found that interferon didn't help these immune cells recover better than those who didn't get interferon.

Methodology

The study analyzed blood samples from multiple myeloma patients and normal volunteers to compare lymphocyte recovery after treatment with high-dose melphalan and interferon.

Limitations

The study did not identify a specific lymphocyte subset that could serve as a prognostic indicator for the anti-proliferative effect of interferon.

Participant Demographics

Patients with multiple myeloma who received various treatment regimens including high-dose melphalan and interferon.

Statistical Information

P-Value

p<0.0002

Statistical Significance

p<0.02

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication